EULAR recommendations for management of fibromyalgia
Ann Rheum Dis
.
2017 Dec;76(12):e54.
doi: 10.1136/annrheumdis-2017-211587.
Epub 2017 May 5.
Authors
Gary J Macfarlane
1
,
Caroline Kronisch
2
,
Fabiola Atzeni
3
,
Winfried Häuser
4
5
,
Ernest H Choy
6
,
Kirstine Amris
7
,
Jaime Branco
8
,
Fitnat Dincer
9
,
Paivi Leino-Arjas
10
,
Kathy Longley
11
,
Geraldine McCarthy
12
,
Suzi Makri
13
,
Serge Perrot
14
,
Piercarlo Sarzi Puttini
15
,
Ann Taylor
6
,
Gareth T Jones
1
Affiliations
1
Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
2
Department of Rheumatology, Cantonal Hospital, Fribourg, Switzerland.
3
ICRCCS Galeazzi Orthopaedic Institute, Milan, Italy.
4
Department of Internal Medicine I, Klinikum Saarbrücken, Saarbrücken, Germany.
5
Department of Psychosomatic Medicine, Technische Universität München, München, Germany.
6
Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
7
Department of Rheumatology, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
8
Department of Rheumatology, CEDOC-NOVA Medical School, UNL, CHLO, Hospital Egas Moniz, Lisbon, Portugal.
9
Department of Physical and Rehabilitation Medicine, Hacettepe University, Division of Internal Medicine, Ankara, Turkey.
10
Finnish Institute of Occupational Health, Helsinki, Finland.
11
Patient Representative, UK.
12
Mater Misericordiae University Hospital, Dublin, Ireland.
13
Patient Representative, Limassol, Cyprus.
14
Centre de la Douleur, Hôpital Cochin-Hôtel Dieu, Université Paris Descartes, Paris, France.
15
Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
PMID:
28476880
DOI:
10.1136/annrheumdis-2017-211587
No abstract available
Keywords:
disease activity; patient perspective; treatment.
Publication types
Letter
Comment
MeSH terms
Evidence-Based Medicine
Exercise Therapy
Fibromyalgia*
Humans